I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Johanns, Tanner
112
results:
Search for persons
X
Format
Online (112)
Mediatypes
Articles (Online) (57)
Bookchapter (Online) (2)
OpenAccess-fulltext (53)
Sorted by: Relevance
Sorted by: Year
?
1
Case report: Increased efficacy of cetuximab after pembroli..:
Morecroft, Renee
;
Phillipps, Jordan
;
Zhou, Alice
...
Frontiers in Oncology. 14 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
2
Addendum: Successful administration of sequential TVEC and ..:
Khaddour, Karam
;
Dowling, Joshua
;
Huang, Jiayi
...
Oncotarget. 14 (2023) 1 - p. 126-126 , 2023
Link:
https://doi.org/10.18632..
?
3
EXTH-02. A TERT-SPECIFIC TCR-LIKE ANTIBODY CAR T CELL APPRO..:
Zhu, Eric
;
Gladney, Susan
;
Ritchey, Julie
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v223-v224 , 2023
Link:
https://doi.org/10.1093/..
?
4
CTIM-10. A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) ..:
Butt, Omar
;
Huang, Jiayi
;
Luo, Jingqin
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii61-vii61 , 2022
Link:
https://doi.org/10.1093/..
?
5
NIMG-43. DIFFUSION BASIS SPECTRUM IMAGING DISTINGUISHES HIG..:
Han, Rowland
;
Johanns, Tanner
;
Blum, Jacob
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii173-vii173 , 2022
Link:
https://doi.org/10.1093/..
?
6
IMMU-30. THE ROLE OF CD4 T CELLS IN ANTITUMOR IMMUNITY AGAI..:
Coxon, Andrew
;
Desai, Rupen
;
Livingstone, Alexandra
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii137-vii138 , 2022
Link:
https://doi.org/10.1093/..
?
7
Use of Belimumab for Prophylaxis of Chronic Graft-Versus-Ho..:
Pusic, Iskra
;
Johanns, Tanner
;
Sarantopoulos, Stefanie
...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S31 , 2022
Link:
https://doi.org/10.1016/..
?
8
CTIM-07. A PHASE I/II STUDY EVALUATING THE SAFETY AND EFFIC..:
Campian, Jian
;
Butt, Omar
;
Luo, Jingqin
...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi50-vi50 , 2021
Link:
https://doi.org/10.1093/..
?
9
CTIM-26. PHASE I/II STUDY OF THE COMBINATION OF PEMBROLIZUM..:
Campian, Jian
;
Butt, Omar
;
Ghinaseddin, Ashley
...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi56-vi56 , 2021
Link:
https://doi.org/10.1093/..
?
10
Salvage Treatment for Recurrent IDH-mutant Diffuse Gliomas ..:
Rudra, Soumon
;
Ma, Sirui
;
Kim, Albert
...
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 2 - p. E28 , 2020
Link:
https://doi.org/10.1016/..
?
11
The Landscape of Novel Therapeutics and Challenges in Gliob..:
Khaddour, Karam
;
Johanns, Tanner
;
Ansstas, George
Pharmaceuticals. 13 (2020) 11 - p. 389 , 2020
Link:
https://doi.org/10.3390/..
?
12
Successful administration of sequential TVEC and pembrolizu..:
Khaddour, Karam
;
Dowling, Joshua
;
Huang, Jiayi
...
Oncotarget. 11 (2020) 52 - p. 4836-4844 , 2020
Link:
https://doi.org/10.18632..
?
13
IMMU-26. UNRAVELING ANTIGEN PRESENTATION IN CENTRAL NERVOUS..:
Bowman-Kirigin, Jay
;
Kobayashi, Dale
;
Livingstone, Alexandra
...
Neuro-Oncology. 22 (2020) Supplement_2 - p. ii110-ii110 , 2020
Link:
https://doi.org/10.1093/..
?
14
Prognostic impact of CDKN2A/B deletion, TERT mutation, and ..:
Ma, Sirui
;
Rudra, Soumon
;
Campian, Jian L
...
Neuro-Oncology Advances. 2 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1093/..
?
15
IMMU-09. COMBINATION IMMUNE TREATMENT OF A HIGHLY AGGRESSIV..:
Liu, Connor
;
Schaettler, Maximilian
;
Bowman-Kirigin, Jay
...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi120-vi121 , 2019
Link:
https://doi.org/10.1093/..
1-15